Drug intelligence / Profile preview

ALPP-targeting CAR-T

Development stage
Preclinical
Lead developer
TCRCure Biotech
Modality
CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

ALPP-targeting CAR-T is a preclinical chimeric antigen receptor (CAR) T-cell therapy being developed by Shanghai Si Dan Race BioTechnology (Innovative Cellular Therapeutics) for the treatment of solid tumors, specifically testicular cancer and ovarian cancer. The therapy is designed using the company's proprietary CoupledCAR platform, which aims to overcome the challenges of CAR-T cell therapy in solid tumors by enhancing the expansion and activation of tumor-targeting CAR-T cells. The CAR-T cells specifically target alkaline phosphatase, placental (ALPP), a cell surface protein ectopically expressed in ovarian and testicular cancers, to selectively eliminate ALPP-expressing tumor cells.

Other names
ALPP CAR-TALPP CoupledCARALPP-targeting CoupledCAR
02

Targets

ALPP (Alkaline phosphatase, placental type)ALPG (Alkaline phosphatase, placental-like 2)

Beyond the preview

Go deeper on ALPP-targeting CAR-T.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALPP-targeting CAR-T.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call